Patanjali unit pulls back illegal ads on heart, liver disorder drugs Farhat Nasim13 Jun 2022 10:00 AM ISTNew Delhi: Patanjali Yogpeeth attached pharmacy has withdrawn advertisements of its ayurvedic products claiming to cure diabetes, heart and liver...
High intake of candies and sodas associated with development of NAFLD Dr. Kamal Kant Kohli13 Jun 2022 8:30 AM ISTFructose as a natural sugar present in fruits, fruit juices, certain vegetables and honey can be part of a nutritious diet. However, fructose is also...
Anti-diabetic drug and NASH: Current Options in 2022 Dr. Kamal Kant Kohli9 Jun 2022 11:06 AM ISTIntroduction and Background Nonalcoholic steatohepatitis (NASH) is a more aggressive form of nonalcoholic fatty liver disease, which can increase the...
Journal Club - Benefits of exercise in fatty liver disease Dr. Nandita Mohan10 May 2022 1:38 PM ISTExercise supports the treatment of non-alcoholic fatty liver disease by impacting on several metabolic pathways in the body. Regular HIIT exercise...
World Liver Day 2022: Highlighting impact of Diabetes on Liver Medical Dialogues Bureau19 April 2022 2:36 PM ISTNew Delhi: World liver day is observed on the 19th April every year and is dedicated to saving liver and avoiding morbidity and mortality because of...
Kisspeptin: A new drug for treatment of NAFLD Dr. Kamal Kant Kohli9 April 2022 10:00 AM ISTGlobally, NAFLD is the most common form of chronic liver disease that affects children and adults and is linked to the rise in obesity and Type 2...
35 percent of Indian population suffer from fatty liver : Dr. SK Sarin MD Bureau20 Feb 2022 9:00 AM ISTNew Delhi: As part of the 'Illness to Wellness' campaign, ASSOCHAM, an apex industry body, conducted a webinar on "Managing Liver Care" with the main...
Bariatric surgery lowers risk of liver and heart complications in patients with NAFLD: JAMA Medha Baranwal20 Nov 2021 9:00 AM ISTBariatric surgery decreases the risk of progression of liver disease, serious heart complications in patients with fatty liver. USA: Bariatric...
Metformin independently reduces mortality in patients with cirrhosis and diabetes: Study Dr. Shravani Dali9 Nov 2021 9:00 AM ISTMetformin exposure in patients with cirrhosis and diabetes appears to be safe and is independently associated with reduced overall, but not...
Fatty pancreas independently associated with development of diabetes: Study Dr. Shravani Dali21 Oct 2021 10:15 AM ISTFatty pancreas is independently associated with subsequent diabetes mellitus (DM), suggests a study published in Clinical Gastroenterology and ...
NASH and NAFLD: Case Based Discussion. Dr Dinesh Jothimani6 Oct 2021 4:29 PM ISTCase Based Discussion on Non-alcoholic steatohepatitis (NASH) and Non-alcoholic fatty liver disease (NAFLD)
Experimental drug shows promise in treatment of NAFLD in phase 2 trial Hina Zahid14 Aug 2021 9:00 AM ISTUSA: An experimental, oral, once-daily, selective fatty acid synthase (FASN) inhibitor has shown promise for the treatment of non-alcoholic...
